Crain's Detroit: Former Aastrom CEO returns to Esperion Theraputics in Plymouth Township
The leadership team of one of the most successful pharmaceutical startups in Michigan history is reuniting, according to a report in Crain’s Detroit Business.
File photo | AnnArbor.com
Newton, who raised nearly $23 million to relaunch the company, will step aside as CEO and take on chief science officer and executive chairmen roles. Mayleben had been CEO and president of Ann Arbor pharma company Aastrom Biosciences until he left in December.
Click here for the full report from Crain’s Detroit Business.